EUCTR2005-005207-42-GB进行中（未招募）1 期
A study to assess the efficacy of a combination of natural plant extracts in natural colds.
Procter & Gamble Technical Centres Limited0 个研究点目标入组 210 人开始时间: 2005年12月5日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 210
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •a) Subject is male or female aged at least 18 years, and in good health;
- •b) Female subjects of child bearing potential have a negative urine pregnancy test and are currently using an acceptable method of birth control, at the discretion of the Investigator;
- •c) Subject thinks that he/she is coming down with a cold, with the first signs of the cold occurring no more than 36 hours prior to Visit 1;
- •d) Subject has a symptom score of 1 or greater for either sore/scratchy throat, runny nose or stuffy/congested nose at Visit 1;
- •e) Subject has a value of 7 or less for the sum of the severity scores across the symptoms assessed at Visit 1 (sore/scratchy throat, runny nose, stuffy/congested nose, cough, tired/run down feeling, chilliness, sneezing, and headache);
- •f) Subject has read, signed, dated, and received a copy of the Informed Consent prior to initiation of the study procedures;
- •g) Subject agrees to avoid alcohol starting at enrollment (Visit 1) and continuing through Day 7;
- •h) Subject agrees to consume 3 or less cups of coffee or other caffeinated beverages per day starting at enrollment (Visit 1) and continuing through Day 7;
- •i) Subject agrees to refrain from taking any products including vitamins, dietary supplements, and homeopathic preparations intended to prevent, intervene in, or treat cough/colds/flu starting at enrollment (Visit 1) and continuing through Day 7 (e.g., those containing vitamin C, zinc, Echinacea); use of a daily multivitamin is allowed;
- •j) Subject agrees to refrain from taking any products including vitamins, dietary supplements, and homeopathic preparations that are intended for sinus/allergy/pain relief starting at enrollment (Visit 1) and continuing through Day 7 (e.g., those containing antihistamines, anticholinergics, decongestants, analgesics); use of low dose aspirin (81-100 mg/day) for cardiac prophylaxis and a daily multivitamin are allowed;
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •a) Have a known hypersensitivity or are allergic to any component of the test products (see section 3.4.3);
- •b) Are breast-feeding, pregnant, or attempting to become pregnant;
- •c) Have had nasal or sinus surgery in the last 2 years or have a clinically significant abnormality of the upper respiratory tract (e.g., chronic nose bleeds, nasal polyp, irreversible nasal mucosal hypertrophy, severe nasal septal deviation);
- •d) Have had a malignancy within the last two years;
- •e) Have or have ever had a respiratory disease (e.g., chronic rhinitis, sinusitis, asthma or reactive airway disease, chronic bronchitis, pneumonia, persistent or chronic cough, emphysema, breathing problems, excessive phlegm or mucus), cardiovascular disease (e.g., myocardial infarction, hypertension), gastrointestinal disease (e.g., hyperacidity, gastrointestinal ulcer, obstruction of bile passages, gall bladder obstruction, gall stones), endocrine disease (e.g., diabetes, thyroid disease, including an overactive thyroid gland), ophthalmic disease (e.g., glaucoma), neurological disease (e.g., epilepsy), urological disease/condition (e.g., an enlarged prostate gland), or hepatic, renal, hematological, or immunological disease;
- •f) Experience frequent headaches/migraines (3 or more times per week);
- •g) Are currently taking medicines containing phenytoin, heparins, antiplatelet agents, thrombolytic agents, anticoagulants, or medicines to treat anxiety or sleep disorders;
- •h) Have taken MAOI (monoamine oxidase inhibitor) drugs within 14 days of Visit 1;
- •i) Have taken any products including vitamins, dietary supplements, and homeopathic preparations intended to prevent, intervene in, or treat cough/colds/flu within 24 hours of Visit 1 (e.g., those containing vitamin C, zinc, Echinacea); use of a daily multivitamin is allowed;
- •j) Have taken any products including vitamins, dietary supplements, and homeopathic preparations that are intended for sinus/allergy/pain relief within 24 hours of Visit 1 (e.g., those containing antihistamines, anticholinergics, decongestants, analgesics); use of low dose aspirin (81-100 mg/day) for cardiac prophylaxis and a daily multivitamin are allowed;
- •k) Are currently experiencing symptoms of respiratory or seasonal allergy;
- •l) Have a temperature greater than 38.3° C at Visit 1;
- •m) Have smoked cigarettes for more than 20 pack/day years (number of pack/day years is number of years smoked times average number of packs smoked per day);
- •n) Have received any investigational drug or participated in a clinical trial within 4 weeks of Visit 1 or are currently enrolled in another investigational study;
- •o) Are related to any study personnel;
- •p) Have a condition or have taken / are currently taking a medication that the Investigator and/or designee believes could jeopardize the safety of the subject, interfere with the evaluation of the study, or confound the interpretation of the study results, or otherwise be considered unsuitable for entry into the study by the Investigator.
研究者
相似试验
已完成
2 期
Assessment of the efficacy of dressings in the treatment of cutaneous leishmaniasis due to Leishmania major: A randomized, single-blind controlled clinical trialCutaneous leishmaniasis.IRCT138707201166N2Tehran University of Medical Sciences210
尚未招募
2 期
To assess the combined effect of Shirodhara, Kalyanaka ghrta and Satvavajaya Chikitsa {Counselling} in Social Anxiety Disorder.CTRI/2019/05/019140Amrita School of Ayurveda
已完成
不适用
A study for evaluating the effect of the combined intake of GABA, extract of Hemerocallis fulva, and extract of Apocynum venetum on sleep: randomized, placebo-controlled, double blind traial, cross-over studyHealthy adultJPRN-UMIN000023431Pharma Foods International Co., Ltd.20
尚未招募
2 期
A Clinical trial to study the effect of two drugs Vishayoga lepa (topical application) and Aragwadadhi kashaya (internal medication) in patients of dadruCTRI/2022/02/040483Shree Dharmasthala Manjunateshwara College Of Ayurveda And HospitalHassan
尚未招募
2 期
Ayurvedic management of Switra (Vitiligo) in childreCTRI/2022/06/042983Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital Hassan